Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$127.2M-1.9%$129.69M-21.3%$164.86M+44.0%$114.45M+40.0%$81.73M+9.3%
$1.95M-23.6%$2.55M+61.1%$1.59M+4.2%$1.52M-67.5%$4.68M+83.3%
$125.25M-1.5%$127.14M-22.1%$163.27M+44.6%$112.93M+46.6%$77.05M+6.7%
98.5%+0.4pp98%-1.0pp99%+0.4pp98.7%+4.4pp94.3%-2.3pp
$57.09M-1.3%$57.87M+11.5%$51.89M+5.1%$49.36M+5.3%$46.89M-24.5%
$80.25M-21.1%$101.69M+17.6%$86.45M+13.4%$76.22M+26.2%$60.41M-13.1%
$164.11M+1.2%$162.12M+15.9%$139.93M+10.1%$127.1M+2.2%$124.41M-8.2%
-$36.92M-13.8%-$32.43M-230%$24.93M+297%-$12.65M+70.4%-$42.67M+29.7%
-29%-4.0pp-25%-40.1pp15.1%+26.2pp-11.1%+41.2pp-52.2%+29.0pp
$2.3M+0.2%$2.3M-16.5%$2.75M-3.3%$2.85M-0.4%$2.86M+1.4%
$193K-98.3%$11.36M+1,351%$783K+1,021%-$85K-106%$1.49M+275%
-$36.72M-74.3%-$21.07M-182%$25.71M+302%-$12.74M+69.1%-$41.19M+31.7%
-$120K-113%$921K+11,413%$8K-60.0%$20K-48.7%$39K
-$37.1M$25.71M+302%-$12.76M+69.1%-$41.23M+31.6%
-29.2%15.6%+26.7pp-11.1%+39.3pp-50.4%+30.1pp
-$0.40$0.28+300%-$0.14+70.2%-$0.47+33.8%
-$11.7M+18.1%-$14.29M-135%$40.72M+2,881%$1.37M+105%-$29.87M+38.6%
-9.2%+1.8pp-11%-35.7pp24.7%+23.5pp1.2%+37.7pp-36.5%+28.5pp
-$36.92M-13.8%-$32.43M-230%$24.93M+297%-$12.65M+70.4%-$42.67M+29.7%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Travere Therapeutics, Inc.'s profit margins?
Gross margin is 98.6% and operating margin is -10.6%, with a -20.3% net margin.
Where does Travere Therapeutics, Inc.'s income statement data come from?
Every line is extracted from Travere Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.